HUMAN PLATELET ANTIGENS (HPA) - ANVISA Registration 80134860216

Access comprehensive regulatory information for HUMAN PLATELET ANTIGENS (HPA) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80134860216 and manufactured by PROGENIKA BIOPHARMA S.L.. The registration is held by GRIFOLS BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 1 companies making the same product including BIOARRAY SOLUTIONS LTD., and 1 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
1 Competitors
80134860216
Registration Details
ANVISA Registration Number: 80134860216
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Registration Details

80134860216

25351609891201586

02513899000171

Company Information

Spain
PT: ESPANHA

Dates and Status

Jun 20, 2016

VIGENTE

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "HUMAN PLATELET ANTIGENS (HPA)"
Recent Registrations
Recently registered products with the same technical name: "HUMAN PLATELET ANTIGENS (HPA)"